Showing results (1001-1010 of 5,919) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|June 27, 2009
Exercise therapy for the management of osteoarthritis of the hip joint: a systematic reviewPeter J McNair, Marion A Simmonds, Mark G Boocock, et al.
Arthritis Research & Therapy|June 23, 2009
Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritisManuela Rossol, Matthias Pierer, Sybille Arnold, et al.
Arthritis Research & Therapy|July 1, 2009
Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximabChristophe Richez, Thierry Schaeverbeke, Chantal Dumoulin, et al.
Arthritis Research & Therapy|January 28, 2009
Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralizedDavid J Hunter, Lou Gerstenfeld, Gavin Bishop, et al.
Arthritis Research & Therapy|January 28, 2009
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synoviumAnak A S S K Dharmapatni, Malcolm D Smith, David M Findlay, et al.
Arthritis Research & Therapy|October 14, 2008
Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritisYoshifumi Tada, Syuichi Koarada, Fumitaka Morito, et al.
Arthritis Research & Therapy|November 19, 2008
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritisHui Geng, Stefan Carlsen, Kutty Selva Nandakumar, et al.
Arthritis Research & Therapy|February 7, 2009
Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependentNoreen Pundt, Marvin A Peters, Christina Wunrau, et al.
Arthritis Research & Therapy|November 19, 2010
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD studySudha Visvanathan, Mahboob U Rahman, Edward Keystone, et al.
Arthritis Research & Therapy|October 20, 2010
Lifestyle factors and lumbar disc disease: results of a German multi-center case-control study (EPILIFT)Barbara Schumann, Ulrich Bolm-Audorff, Annekatrin Bergmann, et al.
Pageof 592